Literature DB >> 19810101

Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005.

Sam M Mbulaiteye1, William F Anderson, Kishor Bhatia, Philip S Rosenberg, Martha S Linet, Susan S Devesa.   

Abstract

Burkitt lymphoma (BL) is a unique B-cell non-Hodgkin lymphoma with 3 established clinical-epidemiological variants: endemic, sporadic and AIDS-related BL. BL variants show characteristic dysregulation of MYC gene, but the causes of MYC dysregulation or BL arising at different ages are poorly understood. Therefore, we examined population-based BL incidence patterns in the United States to determine age-related risk. BL case and population data were obtained from the NCI's Surveillance, Epidemiology and End Results Databases (1973-2005). Standard cross-sectional age-standardized and age-specific incidence rates were stratified by sex and race and supplemented with age-period-cohort models. We analyzed 3,058 BL cases diagnosed during 1,160,300,297 person-years of observation. Age-standardized incidence rates rose 6.8% per year (95% CI 4.5-9.1) for males and 7.1% (95% CI 3.2-11.1) for females during the study period. The rate among males was 3.2 times that among females, and among Whites 1.3 times that among Blacks. Male-to-female incidence rate ratios did not differ by race, but were 4.2 for pediatric (0-19 years), 4.1 for adult (20-59 years) and 2.0 for geriatric (> or = 60 years) BL. Cross-sectional age-specific rates showed 2 separate peaks among males and females, near ages 10 and 75 years, and a 3rd peak near age 40 years among males. The tri/bimodal incidence pattern was present in sensitivity analyses excluding registries with many HIV/AIDS cases and in period-specific, cohort-specific analyses. To our knowledge, tri/bimodal incidence patterns have not previously been reported for BL. Trimodal/bimodal BL suggests heterogeneity in etiology or biology of BL diagnosed at different ages in males and females. (c) 2009 UICC.

Entities:  

Mesh:

Year:  2010        PMID: 19810101      PMCID: PMC2818154          DOI: 10.1002/ijc.24934

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  31 in total

1.  What is Burkitt's lymphoma and when is it endemic?

Authors:  D H Wright
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

2.  Burkitt's lymphoma: a single disease with multiple variants. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues.

Authors:  E S Jaffe; J Diebold; N L Harris; H K Muller-Hermelink; G Flandrin; J W Vardiman
Journal:  Blood       Date:  1999-02-01       Impact factor: 22.113

3.  Epidemiological evidence of the nature of Hodgkin's disease.

Authors:  B MACMAHON
Journal:  Cancer       Date:  1957 Sep-Oct       Impact factor: 6.860

Review 4.  Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.

Authors:  N L Harris; E S Jaffe; J Diebold; G Flandrin; H K Muller-Hermelink; J Vardiman
Journal:  Ann Oncol       Date:  2000       Impact factor: 32.976

5.  NIH clinical staff conference. Burkitt's tumor.

Authors:  P P Carbone; C W Berard; J M Bennett; J L Ziegler; M H Cohen; P Gerber
Journal:  Ann Intern Med       Date:  1969-04       Impact factor: 25.391

6.  Attributable risk percent in case-control studies.

Authors:  P Cole; B MacMahon
Journal:  Br J Prev Soc Med       Date:  1971-11

7.  Evaluation of birth cohort patterns in population disease rates.

Authors:  R E Tarone; K C Chu
Journal:  Am J Epidemiol       Date:  1996-01-01       Impact factor: 4.897

8.  Graphical presentation of trends in rates.

Authors:  S S Devesa; J Donaldson; T Fears
Journal:  Am J Epidemiol       Date:  1995-02-15       Impact factor: 4.897

9.  Hazard function estimation using B-splines.

Authors:  P S Rosenberg
Journal:  Biometrics       Date:  1995-09       Impact factor: 2.571

10.  Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma.

Authors:  Itziar Salaverria; Andreas Zettl; Silvia Beà; Elena M Hartmann; Sandeep S Dave; George W Wright; Evert-Jan Boerma; Philip M Kluin; German Ott; Wing C Chan; Dennis D Weisenburger; Armando Lopez-Guillermo; Randy D Gascoyne; Jan Delabie; Lisa M Rimsza; Rita M Braziel; Elaine S Jaffe; Louis M Staudt; Hans Konrad Müller-Hermelink; Elias Campo; Andreas Rosenwald
Journal:  Haematologica       Date:  2008-08-12       Impact factor: 9.941

View more
  23 in total

1.  AIDS-Related Non-Hodgkin's Lymphoma in Sub-Saharan Africa: Current Status and Realities of Therapeutic Approach.

Authors:  Peter M Mwamba; Walter O Mwanda; Naftaliw Busakhala; R Matthew Strother; Patrick J Loehrer; Scot C Remick
Journal:  Lymphoma       Date:  2012

2.  A web tool for age-period-cohort analysis of cancer incidence and mortality rates.

Authors:  Philip S Rosenberg; David P Check; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-21       Impact factor: 4.254

3.  Age-period-cohort models in cancer surveillance research: ready for prime time?

Authors:  Philip S Rosenberg; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-24       Impact factor: 4.254

4.  Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; H Irene Hall; Jianmin Li; James J Goedert; Lindsay M Morton; Patricia Hartge; Eric A Engels
Journal:  JAMA       Date:  2011-04-13       Impact factor: 56.272

Review 5.  Controversies in the treatment of Burkitt lymphoma in AIDS.

Authors:  Ariela Noy
Journal:  Curr Opin Oncol       Date:  2010-09       Impact factor: 3.645

6.  AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology?

Authors:  Mercy Guech-Ongey; Edgar P Simard; William F Anderson; Eric A Engels; Kishor Bhatia; Susan S Devesa; Sam M Mbulaiteye
Journal:  Blood       Date:  2010-09-02       Impact factor: 22.113

7.  Are incidence rates of adult leukemia in the United States significantly associated with birth cohort?

Authors:  Philip S Rosenberg; Katherine L Wilson; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-12       Impact factor: 4.254

8.  Age-related heterogeneity of Burkitt lymphoma.

Authors:  Sam M Mbulaiteye; William F Anderson
Journal:  Br J Haematol       Date:  2016-07-29       Impact factor: 6.998

9.  Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Sam M Mbulaiteye; Lindsay M Morton; Joshua N Sampson; Ellen T Chang; Laura Costas; Silvia de Sanjosé; Tracy Lightfoot; Jennifer Kelly; Jonathan W Friedberg; Wendy Cozen; Rafael Marcos-Gragera; Susan L Slager; Brenda M Birmann; Dennis D Weisenburger
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

10.  Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009.

Authors:  Sam M Mbulaiteye; Sheeja T Pullarkat; Bharat N Nathwani; Lawrence M Weiss; Nagesh Rao; Benjamin Emmanuel; Charles F Lynch; Brenda Hernandez; Vishala Neppalli; Debra Hawes; Myles G Cockburn; Andre Kim; Makeda Williams; Sean Altekruse; Kishor Bhatia; Marc T Goodman; Wendy Cozen
Journal:  APMIS       Date:  2013-04-23       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.